306935-40-0 Usage
Uses
Used in Pharmaceutical Research:
1,3-Butanedione, 4,4,4-trifluoro-1-(2-thiazolyl)is used as a building block in pharmaceutical research for its potential antifungal and antibacterial properties, contributing to the development of new drugs that target these microorganisms.
Used in Organic Synthesis:
In the field of organic synthesis, 1,3-Butanedione, 4,4,4-trifluoro-1-(2-thiazolyl)is utilized as a key component to construct more complex organic molecules, facilitating the creation of a variety of chemical products.
Used in Food Industry:
1,3-Butanedione, 4,4,4-trifluoro-1-(2-thiazolyl)is used as a flavoring agent in the food industry, enhancing the taste and aroma of various food products.
Used in Cosmetic Industry:
Similarly, in the cosmetic industry, 1,3-Butanedione,4,4,4-trifluoro-1-(2-thiazolyl)- serves as a fragrance agent, adding pleasant scents to cosmetic products.
Safety Note:
It is crucial to handle 1,3-Butanedione, 4,4,4-trifluoro-1-(2-thiazolyl)with care and follow safety guidelines due to its potential health hazards, ensuring the safety of both users and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 306935-40-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,9,3 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 306935-40:
(8*3)+(7*0)+(6*6)+(5*9)+(4*3)+(3*5)+(2*4)+(1*0)=140
140 % 10 = 0
So 306935-40-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H4F3NO2S/c8-7(9,10)5(13)3-4(12)6-11-1-2-14-6/h1-2H,3H2
306935-40-0Relevant academic research and scientific papers
Discovery and structure-activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors
Wang, Ning-Yu,Zuo, Wei-Qiong,Xu, Ying,Gao, Chao,Zeng, Xiu-Xiu,Zhang, Li-Dan,You, Xin-Yu,Peng, Cui-Ting,Shen, Yang,Yang, Sheng-Yong,Wei, Yu-Quan,Yu, Luo-Ting
supporting information, p. 1581 - 1588 (2014/03/21)
Current treatment for hepatitis C is barely satisfactory, there is an urgent need to develop novel agents for combating hepatitis C virus infection. This study discovered a new class of thieno[2,3-b]pyridine derivatives as HCV inhibitors. First, a hit compound characterized by a thienopyridine core was identified in a cell-based screening of our privileged small molecule library. And then, structure activity relationship study of the hit compound led to the discovery of several potent compounds without obvious cytotoxicity in vitro (12c, EC50 = 3.3 μM, SI >30.3, 12b, EC50 = 3.5 μM, SI >28.6, 10l, EC50 = 3.9 μM, SI >25.6, 12o, EC 50 = 4.5 μM, SI >22.2, respectively). Although the mechanism of them had not been clearly elucidated, our preliminary optimization of this class of compounds had provided us a start point to develop new anti-HCV agents.
Xi:Irritant;
